Abstract

This report presents the first benchmarking analysis of green chemistry (GC) adoption across the Indian pharmaceutical supply chain based on data from industry leaders driving such efforts. evaluating the use of green chemistry in the Indian pharmaceutical supply chain Abstract According to the research, Indian companies that make both generic drugs and active pharmaceutical ingredients (APIs) show a strong interest in and progress towards using GC principles. Moreover, 20% of Indian enterprises do not use any GC measurements, and the majority (65%) rely on wastewater treatment and disposal rather than source reduction. The study discovered that when it comes to applying GC principles, generic pharmaceutical businesses are more advanced than API producers. The top two factors mentioned for increasing GC implementation in India were cost savings and environmental laws, whereas regulatory risk and time constraints for medicine delivery were cited as the two biggest obstacles. The report ends with a few recommendations for broadening GC usage in India.